HIV-1 co-receptor tropism in recently diagnosed patients: correlates of CXCR4-use, impact of subtype and indications for X4/DM virus transmission

Size: px
Start display at page:

Download "HIV-1 co-receptor tropism in recently diagnosed patients: correlates of CXCR4-use, impact of subtype and indications for X4/DM virus transmission"

Transcription

1 Poster nr. O_26 HIV-1 co-receptor tropism in recently diagnosed patients: correlates of CXCR4-use, impact of subtype and indications for X4/DM virus transmission Kristen Chalmet, Kenny Dauwe, Lander Foquet, Bea Van Der Gucht, Dirk Vogelaers, Jean Plum, Linos Vandekerckhove and Chris Verhofstede AIDS Reference Laboratory and AIDS Reference Centre, Ghent University, Belgium

2 Patient selection University Hospital Ghent, Belgium Patients newly diagnosed between 2001 to 2009 No follow-up elsewhere, treatment naïve Baseline plasma sample available Willing to participate 579 patients selected

3 Patient information (n=579) Demographics: age, gender, race Infection: route, timing, source Laboratory data: viral load, CD4 count, baseline drug resistance Subtype: B: 60% non-b: 40% CCR5 genotype: wt/wt: 414 (87.5%) wt/ 32: 59 (12.5%) 32/ 32: 0 Co-receptor tropism: population V3 sequencing, Geno2pheno (5.75% and 10% FPR cut off) Successful for 539 individuals: 11.9% X4/DM (5.75%) 19.1% X4/DM (10%)

4 Correlates for tropism X4/DM R5 Patient (total n=539) ,1% 80,9% p-value Age 38 (31-43) 37 (31-44) 0,67 Gender Male 76% 73% Female 24% 27% 0,63 Origin Caucasian 73% 71% 0,70 African 19% 25% 0,26 Other 8% 4% 0,16 CCR5 genotype wt-wt 89% 87% wt-d32 11% 13% 0,63* Transmission route Homosexual 62% 59% 0,65 Heterosexual 33% 38% 0,42 IVDU (n=8) 5% 1% 0,05 Other 0% 1% 0,59 Transmitted drug resistance Yes (n=38) 13% 6% No 87% 94% 0,01 * p=0,57 when analyzing Caucasians only

5 Baseline CD4 count Patient n=539 X4/DM R ,1% 80,9% p-value Baseline CD4 count Median (IQR) 360 ( ) 385 ( ) 0,012 CD4 <200 (n=108) 33% 17% <0,001 Viral load Patient n=539 X4/DM R ,1% 80,9% p-value Baseline viral load Median (IQR) 4,6 (4,0-5,0) 4,5 (3,9-5,0) 0,27 VL > 100,000 c/ml 29% 27% 0,59

6 HIV-1 subtype Patient n=539 X4/DM R ,1% 80,9% p-value Subtype B (n=323) 55% 61% non-b (n=216) 45% 39% Patient n=539 X4/DM R ,1% 80,9% 0,29 p-value Subtype B % 61% C 31 5% 6% 0,66 A 34 7% 6% 0,83 01_AE 43 17% 6% <0,001 02_AG 58 8% 11% 0,30 Other 50 9% 9% 0,83

7 Conclusions (part 1) 103/539 (19.1%) of newly diagnosed patients were infected with X4/DM viruses (G2P 10%FPR). Presence of X4/DM virus was associated with lower CD4 counts but not with higher viral load. Presence of X4/DM virus was not associated with the wt/ 32 CCR5 genotype Significant higher prevalence of X4/DM viruses in patients infected with the 01_AE subtype

8 Phylogenetic analysis based on baseline PR/RT sequences B PR-RT sequences contain sufficient information for phylogenetic analysis and localization of transmission events (Hue Non-B et al. AIDS 2004; 18: ) NJ & Bayesian analysis - construction of phylogenetic tree 0.1 Chalmet et al. 2010, BMC Infectious Diseases, 10, 262.

9 Transmission events 2 out of 3 criteria fullfilled: B bootstrap value 90, mean genetic distance Non-B 0.015, posterior probability = 1 Identification of 63 transmission clusters (261 individuals) Chalmet et al. 2010, BMC Infectious Diseases, 10, 262.

10 Distribution of X4/DM and R5 in the phylogenetic trees Non-B B Blue branches: transmission cluster Red stars: X4/DM virus

11 Localization of X4/DM and R5 viruses in the phylogenetic tree X4/DM R5 n Patients Patients Patients Separate branches (19,9%) 225 (80,9%) Clustered branches (18,4%) 213 (81,6%) X4/DM R5 X4/DM + R5 n (pts) n (pts) n (pts) n (pts) Transmission clusters 63 (261) 7 (20) 38 (167) 18 (74) Clusters (=2) 5 Clusters (>=3) 2 (5) X4/DM viruses only in 7/63 (11.1%) of all clusters

12 X4/DM cluster -MSM - Not IVDU - Almost identical PR-RT and V3 sequences - Epidemiological link (n=3) - Acute infection (n=3) - Phenotype: DM (n=1); MT2 positive virus (n=2)

13 Tropism in transmission pairs 38 transmission pairs localized in the phylogenetic tree Selection of transmission pairs also identified as most probable source and receptor with a genetic distance in pol of <= n X4/DM R5 Both Source-receptor couples 13 4 (31%) 9 (69%) 0 2 HoS/ 2 HeS 2 B/ 2 non-b 7 HoS/ 2 HeS 7 B/ 2 non-b

14 Conclusions (part 2) Viruses reported as X4/DM (FPR <10%) can be readily transmitted. Overall X4/DM incidence in newly diagnosed individuals: 19.1% X4/DM in transmission clusters: 11.1% X4/DM in transmission pairs: 31% This observation DOES NOT exclude the use of the CCR5 receptor at transmission but warrants a rethinking of the dogma that mainly R5 strains are transmitted. Patients can become infected with viral strains known to be associated with a faster immune deterioration and an intrinsic resistance to CCR5 inhibitors.

15 Acknowledgements ARL ARC Kristen Chalmet Kenny Dauwe Jacqueline Reynaerts Els Demecheleer Delfien Staelens Marlies Schauvliege Jean Plum Dirk Vogelaers Linos Vandekerckhove Bea Vandergucht Jolanda Pelgrom Filip Van Wanzeele Steven Callens Erica Sermyn Ghent University The patients

CD4 + T-cell-inducing HIV vaccines may have an impact on viral control

CD4 + T-cell-inducing HIV vaccines may have an impact on viral control CD4 + T-cell-inducing HIV vaccines may have an impact on viral control Clues from cytokines produced by CD4 + T-cells from HIVinfected patients and vaccinated seronegative volunteers Eva Van Braeckel 1,

More information

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per

More information

Yale University, New Haven, CT, USA

Yale University, New Haven, CT, USA HEPATITIS C VIRUS INFECTION IS UBIQUITOUS AMONG DRUG INJECTORS IN ST. PETERSBURG, RF Robert Heimer 1, Elijah Paintsil 1, Sergei Verevochkin 2, Russell Barbour 1, Edward d White 1, Olga Toussova 2, Linda

More information

Three factors were independently associated with a low degree of connectivity in the clusters:

Three factors were independently associated with a low degree of connectivity in the clusters: HIV Transmission Clusters Offer Clues to HIV Risk in Young Black MSM 21st International AIDS Conference (AIDS 2016), July 18-22, 2016, Durban, South Africa Mark Mascolini Phylogenetic analysis of young

More information

Journal of Infectious Diseases Advance Access published April 18, Using Ultradeep Pyrosequencing to Study HIV 1 Co receptor Usage in Primary and

Journal of Infectious Diseases Advance Access published April 18, Using Ultradeep Pyrosequencing to Study HIV 1 Co receptor Usage in Primary and Journal of Infectious Diseases Advance Access published April 18, 2013 1 Using Ultradeep Pyrosequencing to Study HIV 1 Co receptor Usage in Primary and Dual Infection Gabriel A. Wagner 1, Mary E. Pacold

More information

High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01Binfected HIV-1 subjects in Singapore

High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01Binfected HIV-1 subjects in Singapore Ng et al. BMC Infectious Diseases 2013, 13:90 RESEARCH ARTICLE Open Access High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01Binfected HIV-1 subjects in Singapore Kah Ying Ng 1,

More information

Meticulous plasma isolation is essential to avoid false low-level viraemia in Roche Cobas HIV-1 viral load assays

Meticulous plasma isolation is essential to avoid false low-level viraemia in Roche Cobas HIV-1 viral load assays Meticulous plasma isolation is essential to avoid false low-level viraemia in Roche Cobas HIV-1 viral load assays Virginie Mortier, Leen Vancoillie, Kenny Dauwe, Delfien Staelens, Els Demecheleer, Marlies

More information

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING John Archer Faculty of Life Sciences University of Manchester HIV Dynamics and Evolution, 2008, Santa Fe, New Mexico. Overview

More information

PRO140 SC Monotherapy (MT) Provides Long-Term, Full Virologic Suppression in HIV Patients

PRO140 SC Monotherapy (MT) Provides Long-Term, Full Virologic Suppression in HIV Patients PRO140 SC Monotherapy (MT) Provides Long-Term, Full Virologic Suppression in HIV Patients Jay Lalezari, Kush Dhody, Ula Kowalczyk, Kazem Kazempour, Nader Pourhassan, and Paul J. Maddon 1 ASM Microbe 2016

More information

Follow-up investigation of a cluster of treatment-naïve HIV-infected patients with multi-drug resistance in Sudbury, Ontario

Follow-up investigation of a cluster of treatment-naïve HIV-infected patients with multi-drug resistance in Sudbury, Ontario Follow-up investigation of a cluster of treatment-naïve HIV-infected patients with multi-drug resistance in Sudbury, Ontario Ashleigh Sullivan, Penny Sutcliffe, Roger Sandre, P. Richard Harrigan, Chris

More information

Laboratory Testing for HIV Tropism

Laboratory Testing for HIV Tropism Laboratory Testing for HIV Tropism Policy Number: 2.04.49 Last Review: 6/2018 Origination: 6/2015 Next Review: 6/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for

More information

Phylodynamics of HIV-1 Subtype B among the Men- Having-Sex-with-Men (MSM) Population in Hong Kong

Phylodynamics of HIV-1 Subtype B among the Men- Having-Sex-with-Men (MSM) Population in Hong Kong Phylodynamics of HIV-1 Subtype B among the Men- Having-Sex-with-Men (MSM) Population in Hong Kong Jonathan Hon-Kwan Chen 1,3, Ka-Hing Wong 2, Kenny Chi-Wai Chan 2, Sabrina Wai-Chi To 1, Zhiwei Chen 3,

More information

Abstract. Introduction

Abstract. Introduction Evidence That HIV-1 CRF01_AE Is Associated with Low CD4+T Cell Count and CXCR4 Co-Receptor Usage in Recently Infected Young Men Who Have Sex with Men (MSM) in Shanghai, China Xiaoshan Li 1,2., Yile Xue

More information

A phylodynamic analysis of HIV-1 in Germany

A phylodynamic analysis of HIV-1 in Germany A phylodynamic analysis of HIV-1 in Germany Prabhav Kalaghatgi Max Planck Institute for Informatics, Saarbrücken RKI workshop 2015, Berlin Number of cases Incidence of HIV-1 in Western Europe Figure 2.

More information

Molecular Surveillance of Recent HIV-Infections in Germany. Priv.-Doz. Dr. Norbert Bannert "HIV und Other Retroviruses" Robert Koch-Institut, Berlin

Molecular Surveillance of Recent HIV-Infections in Germany. Priv.-Doz. Dr. Norbert Bannert HIV und Other Retroviruses Robert Koch-Institut, Berlin Molecular Surveillance of Recent HIV-Infections in Germany Priv.-Doz. Dr. Norbert Bannert "HIV und Other Retroviruses" Robert Koch-Institut, Berlin AREVIR-Meeting, May 9th 2015 Sampling of New HIV Diagnoses

More information

Case Study. Dr Sarah Sasson Immunopathology Registrar. HIV, Immunology and Infectious Diseases Department and SydPath, St Vincent's Hospital.

Case Study. Dr Sarah Sasson Immunopathology Registrar. HIV, Immunology and Infectious Diseases Department and SydPath, St Vincent's Hospital. Case Study Dr Sarah Sasson Immunopathology Registrar HIV, Immunology and Infectious Diseases Department and SydPath, St Vincent's Hospital Case 1: Case 1: 45F in Cameroon Cameroon HIV+ Presents with cutaneous

More information

Community oriented studies. New perspectives

Community oriented studies. New perspectives Community oriented studies. New perspectives Swiss HIV Cohort Study Increased Viral Load Suppression in HIV+ Persons on ART Cohort size: 4624 4852 5045 5279 5556 5830 6121 6418 6526 100 Percent of individuals

More information

HIV treatment cascade and epidemiological analysis of the new HIV outbreak in injecting drug users from Luxembourg

HIV treatment cascade and epidemiological analysis of the new HIV outbreak in injecting drug users from Luxembourg HIV treatment cascade and epidemiological analysis of the new HIV outbreak in injecting drug users from Luxembourg Carole Devaux, PhD Infectious Diseases Research Unit Department of Infection and immunity

More information

Tracing HIV 1 transmission: envelope traits of HIV 1 transmitter and recipient pairs

Tracing HIV 1 transmission: envelope traits of HIV 1 transmitter and recipient pairs DOI 10.1186/s12977-016-0299-0 Retrovirology RESEARCH Open Access Tracing HIV 1 transmission: envelope traits of HIV 1 transmitter and recipient pairs Corinna S. Oberle 1,2, Beda Joos 1,2, Peter Rusert

More information

HIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense

HIV/AIDS & Immune Evasion Strategies. The Year First Encounter: Dr. Michael Gottleib. Micro 320: Infectious Disease & Defense Micro 320: Infectious Disease & Defense HIV/AIDS & Immune Evasion Strategies Wilmore Webley Dept. of Microbiology The Year 1981 Reported by MS Gottlieb, MD, HM Schanker, MD, PT Fan, MD, A Saxon, MD, JD

More information

An Evolutionary Story about HIV

An Evolutionary Story about HIV An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst

More information

6/10/2015. Background. Background. Background. Background. Methods

6/10/2015. Background. Background. Background. Background. Methods /1/1 The challenges of diversity: HIV-1 subtype distribution and transmission s within the Australian Molecular Epidemiology Network-HIV -1 Castley A, Sawleshwarkar S, Varma R, Herring B, Thapa K, Chibo

More information

JCM (Revised version, June 23 th 2011)

JCM (Revised version, June 23 th 2011) JCM Accepts, published online ahead of print on 6 July 2011 J. Clin. Microbiol. doi:10.1128/jcm.00908-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

Ongoing HIV-1 subtype B transmission networks amongst MSM in the Netherlands. Daniela Bezemer. HIV Monitoring Foundation Amsterdam The Netherlands

Ongoing HIV-1 subtype B transmission networks amongst MSM in the Netherlands. Daniela Bezemer. HIV Monitoring Foundation Amsterdam The Netherlands Ongoing HIV-1 subtype B transmission networks amongst MSM in the Netherlands Daniela Bezemer HIV Monitoring Foundation Amsterdam The Netherlands MSM = men who have sex with men NCHIV 2013 Background Resurgent

More information

BHIVA Workshop: When to Start. Dr Chloe Orkin Dr Laura Waters

BHIVA Workshop: When to Start. Dr Chloe Orkin Dr Laura Waters BHIVA Workshop: When to Start Dr Chloe Orkin Dr Laura Waters Aims To use cases to: Review new BHIVA guidance Explore current data around when to start To discuss: Medical decisions, pros and cons Luigi

More information

Deep Sequencing Detects V3 loop Forms Present in Functional X4 Viruses Growing in MT 2 assays

Deep Sequencing Detects V3 loop Forms Present in Functional X4 Viruses Growing in MT 2 assays Deep Sequencing Detects V3 loop Forms Present in Functional X4 Viruses Growing in MT 2 assays Christian Pou 1, Rocío Bellido 1, Francisco M. Codoñer 1, Alexander Thielen 3, Cecilia Cabrera 1, Judith Dalmau

More information

ID Week 2016: HIV Update

ID Week 2016: HIV Update Mountain West AIDS Education and Training Center ID Week 2016: HIV Update Robert Harrington, M.D. This presentation is intended for educational use only, and does not in any way constitute medical consultation

More information

Update on HIV-1 Drug Resistance and Tropism Testing

Update on HIV-1 Drug Resistance and Tropism Testing Update on HIV-1 Drug Resistance and Tropism Testing Daniel R. Kuritzkes, MD Section of Retroviral Therapeutics Brigham and Women s Hospital Harvard Medical School ACTHIV 2011: A State-of-the-Science Conference

More information

ORIGINAL ARTICLE /j x. Brescia, Italy

ORIGINAL ARTICLE /j x. Brescia, Italy ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.00938.x Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive

More information

The BLAST search on NCBI ( and GISAID

The BLAST search on NCBI (    and GISAID Supplemental materials and methods The BLAST search on NCBI (http:// www.ncbi.nlm.nih.gov) and GISAID (http://www.platform.gisaid.org) showed that hemagglutinin (HA) gene of North American H5N1, H5N2 and

More information

Derivation of population mixing patterns from virus sequence data and their impacts on the modelling of HIV epidemics in MSM

Derivation of population mixing patterns from virus sequence data and their impacts on the modelling of HIV epidemics in MSM Derivation of population mixing patterns from virus sequence data and their impacts on the modelling of HIV epidemics in MSM Ngai Sze WONG 1 ; Tsz Ho KWAN 2 ; Kenny CW CHAN 3 ; Owen TY TSANG 4 ; Man Po

More information

Understanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute

Understanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute Understanding HIV Transmission Utilizing Transmitted/Founder Viruses Brandon Keele SAIC-Frederick National Cancer Institute AIDS Vaccine 2011 15 September 2011 Overview Several years ago, the CHAVI sought

More information

An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008

An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008 An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs Debrah Boeras Emory University October 14, 2008 Background A majority of HIV-1 infections occur through heterosexual exposure

More information

Supplementary Materials

Supplementary Materials 1 Supplementary Materials Rotger et al. Table S1A: Demographic characteristics of study participants. VNP RP EC CP (n=6) (n=66) (n=9) (n=5) Male gender, n(%) 5 (83) 54 (82) 5 (56) 3 (60) White ethnicity,

More information

Fertility Desires/Management of Serodiscordant HIV + Couples

Fertility Desires/Management of Serodiscordant HIV + Couples Fertility Desires/Management of Serodiscordant HIV + Couples William R. Short, MD, MPH Assistant Professor of Medicine Division Of Infectious Diseases Jefferson Medical College of Thomas Jefferson University

More information

Transmission of integrase resistance HIV

Transmission of integrase resistance HIV Transmission of integrase resistance HIV Charles Boucher, MD, PhD Clinical Virology, Dept. Viroscience, Erasmus Medical Center, Erasmus Universiy, The Netherlands Major resistance mutations (Stanford)

More information

Q and A - the PARTNER Study: new results from PARTNER 2

Q and A - the PARTNER Study: new results from PARTNER 2 Q and A - the PARTNER Study: new results from PARTNER 2 1. Study results What is the PARTNER Study? The PARTNER study is an international two-phase study that looked at whether HIV transmission occurs

More information

Resistance Workshop. 3rd European HIV Drug

Resistance Workshop. 3rd European HIV Drug 3rd European HIV Drug Resistance Workshop March 30-April 1 st, 2005 Christine Hughes, PharmD Clinical Associate Professor Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Tenofovir resistance

More information

COMET: Rapid and reliable HCV subtype predictor

COMET: Rapid and reliable HCV subtype predictor COMET: Rapid and reliable HCV subtype predictor (Context-based Modeling for Expeditious Typing) Daniel Struck CRP-SANTÉ Laboratory of Retrovirology (daniel.struck@crp-sante.lu) Background HCV genotype/subtype

More information

Patterns of Resistance to Antiretroviral Therapy among HIV+ Patients in Clinical Care

Patterns of Resistance to Antiretroviral Therapy among HIV+ Patients in Clinical Care Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 11-15-2006 Patterns of Resistance to Antiretroviral Therapy among

More information

Evaluation of Dried Blood Spots (DBS) for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing

Evaluation of Dried Blood Spots (DBS) for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing Evaluation of Dried Blood Spots (DBS) for Human Immunodeficiency Virus (HIV-1) Drug Resistance Testing Dawit Assefa 2, Woldaregay E.Abegaz 3, Teferi Gedif 2, Belete Tegbaru 1, Dereje Teshome 1, Tesfaye

More information

BALTIMORE COUNTY HIV/AIDS EPIDEMIOLOGICAL PROFILE Fourth Quarter Data reported throuh December 31, 2007

BALTIMORE COUNTY HIV/AIDS EPIDEMIOLOGICAL PROFILE Fourth Quarter Data reported throuh December 31, 2007 Fourth Quarter 2007 - Data reported throuh AIDS Administration Maryland Department of Health and Mental Hygiene www.dhmh.state.md.us/aids/ 1-800-358-9001 SPECIAL NOTE ON HIV REPORTING The Maryland HIV/AIDS

More information

MANITOBA HIV REPORT 2015

MANITOBA HIV REPORT 2015 MANITOBA HIV REPORT 2015 The Manitoba HIV Program provides information, specialized care, treatment, and support to approximately 1,250 people living with HIV across the province. The Program has two Winnipeg-based

More information

HIV/AIDS CLINICAL CARE QUALITY MANAGEMENT CHART REVIEW CHARACTERISTICS OF PATIENTS FACTORS ASSOCIATED WITH IMPROVED IMMUNOLOGIC STATUS

HIV/AIDS CLINICAL CARE QUALITY MANAGEMENT CHART REVIEW CHARACTERISTICS OF PATIENTS FACTORS ASSOCIATED WITH IMPROVED IMMUNOLOGIC STATUS HIV/AIDS CLINICAL CARE QUALITY MANAGEMENT CHART REVIEW CHARACTERISTICS OF PATIENTS WITH LOW CD4 COUNTS IN 2008 AND FACTORS ASSOCIATED WITH IMPROVED IMMUNOLOGIC STATUS FROM 2004 THROUGH 2008 For the Boston

More information

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES 1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.

More information

Geospatial Targeting of Young HIV-infected Men who have Sex with Men (YMSM) in CNICS

Geospatial Targeting of Young HIV-infected Men who have Sex with Men (YMSM) in CNICS Geospatial Targeting of Young HIV-infected Men who have Sex with Men (YMSM) in CNICS Patrick Loose, Chief, SDHHS HIV, STD, and Hepatitis Branch Sheldon Morris M.D., M.P.H. University of California, San

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

HIV-1 Dual Infection and Neurocognitive Impairment

HIV-1 Dual Infection and Neurocognitive Impairment HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral

More information

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD 17 May 2018 Bucharest, Romania Organisers Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe

More information

Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA

Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA HIV Genotypischer Resistenzalgorithmus Deutschland Multicenter comparison of genotypic tropism testing: results from viral RNA and proviral DNA Financial disclosure Study was financially supported by ViiV

More information

Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System

Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Joel O. Wertheim 1,2, Alexandra M. Oster 3, Jeffrey A. Johnson 3, William M. Switzer 3, Neeraja Saduvala

More information

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious

More information

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Dr. Fausta Franklin Mosha (MD, MSc, MSc, PHD) Ministry of Health and Social Welfare 22 nd October

More information

HIV Drug Resistance. Together, we can change the course of the HIV epidemic one woman at a time.

HIV Drug Resistance. Together, we can change the course of the HIV epidemic one woman at a time. HIV Drug Resistance Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Resistance? HIV drugs are designed to keep the amount of HIV virus

More information

Mapping the Antigenic and Genetic Evolution of Influenza Virus

Mapping the Antigenic and Genetic Evolution of Influenza Virus Mapping the Antigenic and Genetic Evolution of Influenza Virus Derek J. Smith, Alan S. Lapedes, Jan C. de Jong, Theo M. Bestebroer, Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Ron A. M. Fouchier Science

More information

Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement

Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Leander Schietgat 1, Kristof Theys 2, Jan Ramon 1, Hendrik Blockeel 1, and Anne-Mieke Vandamme

More information

Immunodeficiency. (2 of 2)

Immunodeficiency. (2 of 2) Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related

More information

Charles Boucher MD. PhD. HIV Prevention 2.0

Charles Boucher MD. PhD. HIV Prevention 2.0 Charles Boucher MD. PhD HIV Prevention 2.0 Prevention A variety of methods exists to prevent transmission of HIV Circumcision Condoms Post-exposure profylaxe (PEP) Treatment as prevention Pre-exposure

More information

Evolution and Diversity of HIV in Southeastern Michigan

Evolution and Diversity of HIV in Southeastern Michigan Evolution and Diversity of HIV in Southeastern Michigan Erik M Volz Department of Epidemiology, University of Michigan Ann Arbor April 20, 2011 Erik M Volz Phylodynamics 1 / 28 The HIV epidemic in Southeastern

More information

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set Sexually Transmitted Infection, including HIV, 213 Health Protection Scotland Slide Set Enhanced surveillance systems are employed to give more detailed information on the epidemiology of infectious syphilis

More information

Integrase strand-transfer inhibitors primary resistance in patients with acute/recent HIV infection

Integrase strand-transfer inhibitors primary resistance in patients with acute/recent HIV infection Integrase strand-transfer inhibitors primary resistance in patients with acute/recent HIV infection Juan Ambrosioni, David Nicolás, Christian Manzardo, Fernando Agüero, José Luis Blanco, Maria del Mar

More information

Round table discussion Patients with multiresistant virus : A limited number, but a remarkable deal Introduction

Round table discussion Patients with multiresistant virus : A limited number, but a remarkable deal Introduction Disclosure statement: Dr. Santoro reports personal fees from ViiV Healthcare, Gilead and JANSSEN Cilag Round table discussion Patients with multiresistant virus : A limited number, but a remarkable deal

More information

Technical appendix to How should access to antiretroviral treatment be measured? Published in the Bulletin of the World Health Organization

Technical appendix to How should access to antiretroviral treatment be measured? Published in the Bulletin of the World Health Organization Technical appendix to How should access to antiretroviral treatment be measured? Published in the Bulletin of the World Health Organization Leigh F. Johnson Andrew Boulle Centre for Infectious Disease

More information

European guidelines on the clinical management of HIV-1 tropism testing

European guidelines on the clinical management of HIV-1 tropism testing European guidelines on the clinical management of HIV-1 tropism testing L P R Vandekerckhove*, A M J Wensing*, R Kaiser, F Brun-Vézinet, B Clotet, A De Luca, S Dressler, F Garcia, A M Geretti, T Klimkait,

More information

Clinical and Public Health Policy Implications of Findings that:

Clinical and Public Health Policy Implications of Findings that: Clinical and Public Health Policy Implications of Findings that: Adherence to HIV Medications and Emotional/Physiological Coping with Stress are Independently Associated with Specific Five-Year Outcome

More information

Use of molecular surveillance data to identify clusters of recent and rapid HIV transmission

Use of molecular surveillance data to identify clusters of recent and rapid HIV transmission National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Use of molecular surveillance data to identify clusters of recent and rapid HIV transmission Alexa Oster, MD Acting Lead, Incidence

More information

What s New in Acute HIV Infection?

What s New in Acute HIV Infection? 3 4 Disclosure I have received research grants awarded to my institution from Gilead Sciences, Inc. ntiretroviral medications have been provided by Gilead Sciences, Inc. Susan Little, M.D. Professor of

More information

Determination of the High Prevalence of Dual/Mixed- or X4- Tropism Among HIV Type 1 CRF01_AE in Hong Kong by Genotyping and Phenotyping Methods

Determination of the High Prevalence of Dual/Mixed- or X4- Tropism Among HIV Type 1 CRF01_AE in Hong Kong by Genotyping and Phenotyping Methods Title Determination of the High Prevalence of Dual/Mixed- or X4- Tropism Among HIV Type 1 CRF01_AE in Hong Kong by Genotyping and Phenotyping Methods Author(s) To, SWC; Chen, JHK; Wong, K; Chan, K; Chen,

More information

Rapidly Growing Molecular Clusters of HIV in Texas. Analise Monterosso, MPH Epidemiologist Molecular HIV Surveillance Coordinator

Rapidly Growing Molecular Clusters of HIV in Texas. Analise Monterosso, MPH Epidemiologist Molecular HIV Surveillance Coordinator Rapidly Growing Molecular Clusters of HIV in Texas Analise Monterosso, MPH Epidemiologist Molecular HIV Surveillance Coordinator Outline HIV in Texas HIV Drug Resistance testing (genotyping) in Texas Molecular

More information

Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism

Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism Meini et al. BMC Infectious Diseases 2013, 13:508 TECHNICAL ADVANCE Open Access Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism Genny Meini 1*, Angelo Materazzi

More information

MID-TERM EXAMINATION

MID-TERM EXAMINATION Epidemiology 227 May 2, 2007 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 75 questions and 11 pages on the examination. Each question will count one point. Notify

More information

Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection

Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection The Harvard community has made this article openly available. Please share how this access benefits you. Your story

More information

HIV-1 subtype C in Karonga District, Malawi. Simon Travers

HIV-1 subtype C in Karonga District, Malawi. Simon Travers HIV-1 subtype C in Karonga District, Malawi Simon Travers HIV-1; closely related to HIV found in chimps HIV-2; closely related to HIV found in mangabys Worldwide Distribution of HIV-1 group M subtypes

More information

CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression

CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression Stéphanie Raymond a,b,c, Pierre Delobel a,b,d, Maud Mavigner a, Michelle

More information

Sexual Networks: Challenges (and Opportunities)

Sexual Networks: Challenges (and Opportunities) Sexual Networks: Challenges (and Opportunities) Susan Little, M.D. Professor of Medicine University of California San Diego 1 Network Theory What network theory teaches us is that connections, even within

More information

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.

More information

Background. A systematic analysis from previous studies reported the following prevalence:

Background. A systematic analysis from previous studies reported the following prevalence: High levels of resistance among HIV-1 treatment naive patients in Greece. a nationwide study: Evidence for country and regional level transmission networks D. Paraskevis 1. E. Kostaki 1. G. Magiorkinis

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH Considerations

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH Considerations INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations General Principles to Address Virus and Vector Shedding 1.0 Introduction

More information

HIV-1 acute infection: evidence for selection?

HIV-1 acute infection: evidence for selection? HIV-1 acute infection: evidence for selection? ROLLAND Morgane University of Washington Cohort & data S6 S5 T4 S4 T2 S2 T1 S1 S7 T3 DPS (days post symptoms) 3 (Fiebig I) 7 (Fiebig I) 13 (Fiebig V) 14 (Fiebig

More information

Monitoring Recent HIV Infection in Ireland, 2017

Monitoring Recent HIV Infection in Ireland, 2017 Monitoring Recent HIV Infection in Ireland, 2017 January 2019 Key Facts 1 13% of HIV diagnoses in 2017 (of those tested) were likely to be recent infections (within 4 months), using the Recent Infection

More information

Inter-country mixing in HIV transmission clusters: A pan-european phylodynamic study

Inter-country mixing in HIV transmission clusters: A pan-european phylodynamic study Inter-country mixing in HIV transmission clusters: A pan-european phylodynamic study Prabhav Kalaghatgi Max Planck Institute for Informatics March 20th 2013 HIV epidemic (2009) Prabhav Kalaghatgi 2/18

More information

AIDS Research and Therapy. Open Access RESEARCH

AIDS Research and Therapy. Open Access RESEARCH https://doi.org/.1186/s12981-18-26-y AIDS Research and Therapy RESEARCH Open Access Characterization of minority HIV 1 drug resistant variants in the United Kingdom following the verification of a deep

More information

Clinical Case. Prof.ssa Cristina Mussini

Clinical Case. Prof.ssa Cristina Mussini Clinical Case Prof.ssa Cristina Mussini Clinical history Male, born in Ivory Coast in 1968. HIV positive since dal 1998 Risk factor: heterosexual contacts He started antiretroviral therapy in 2001 with

More information

Switching from combination antiretroviral therapy to DOlutegravir MONOtherapy in virologically suppressed HIV-1 infected adults:

Switching from combination antiretroviral therapy to DOlutegravir MONOtherapy in virologically suppressed HIV-1 infected adults: Switching from combination antiretroviral therapy to DOlutegravir MONOtherapy in virologically suppressed HIV-1 infected adults: A randomized multicenter, non-inferiority clinical trial (DOMONO) Ingeborg

More information

Received 4 August 2005/Accepted 7 December 2005

Received 4 August 2005/Accepted 7 December 2005 JOURNAL OF VIROLOGY, Mar. 2006, p. 2472 2482 Vol. 80, No. 5 0022-538X/06/$08.00 0 doi:10.1128/jvi.80.5.2472 2482.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Extensive Recombination

More information

Missouri St. Louis TGA 2016 HIV Epidemiological Profile

Missouri St. Louis TGA 2016 HIV Epidemiological Profile Missouri St. Louis TGA 2016 HIV Epidemiological Profile St. Louis TGA Part A Planning Council Prepared by the City of St. Louis Department of Health Center for Health Information, Research, and Planning

More information

PEP and PREP. Dr David Hawkins Chelsea and Westminster Hospital

PEP and PREP. Dr David Hawkins Chelsea and Westminster Hospital PEP and PREP Dr David Hawkins Chelsea and Westminster Hospital Opportunities for biomedical interventions YEARS HOURS 72 HOURS YEARS Prior to exposure Exposure (pre-coital/ coital) Exposure (pre-coital/

More information

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016 New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 6 Table of Contents. Introduction.... Methodology... 3. Data Limitations.... Definitions used... 3 5. Overview of STBBI epidemiology

More information

A new wild-type in the era of transmitted drug resistance

A new wild-type in the era of transmitted drug resistance A new wild-type in the era of transmitted drug resistance EHR 2018 Rome KU Leuven 1 A new wild-type in the era of transmitted drug resistance? KU Leuven 2 Measurably evolving viruses Evolutionary rate

More information

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems Highlight Disease: Malaria World s dominant protozoal disease. Four species of Plasmodium: P. falciparum (malignant), P. vivax (begnin),

More information

Improving Utilization of Organs from Increased Risk Donors. Matthew J. Kuehnert, MD CDC

Improving Utilization of Organs from Increased Risk Donors. Matthew J. Kuehnert, MD CDC Improving Utilization of Organs from Increased Risk Donors Matthew J. Kuehnert, MD CDC Conflict of Interest Disclosure I have no relevant financial relationships to disclose. 2016 AST Improving Utilization

More information

Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCD ID Cohort

Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCD ID Cohort Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCD ID Cohort A. Lacey 1, W. Tinago 1, E. Alvarez Barco 1, A.J. Macken

More information

HIV long term complications

HIV long term complications HIV- 2015 long term complications 4th Asian Conference on Hepatitis & AIDS 22-23 May 2015, Xi'an, China Kees Brinkman Amsterdam The Netherlands NL 2012: known 17.000 (0,1%) treatment 85% (all) China 2011:

More information

Implications of HIV variability for transmission: scientific and policy issues

Implications of HIV variability for transmission: scientific and policy issues SPECIAL REPORT Implications of HIV variability for transmission: scientific and policy issues Expert Group of the Joint United Nations Programme on HIV/AIDS* AIDS 1997, 11:UNAIDS1 UNAIDS15 Keywords: HIV

More information

SUPPLEMENTARY FIG. S1. MVC inhibition curves in NP2-CD4/CCR5 cells. Luciferase reporter viruses pseudotyped with baseline (black solid lines) and MVC

SUPPLEMENTARY FIG. S1. MVC inhibition curves in NP2-CD4/CCR5 cells. Luciferase reporter viruses pseudotyped with baseline (black solid lines) and MVC Supplementary Data SUPPLEMENTARY FIG. S1. MVC inhibition curves in NP2-CD4/CCR5 cells. Luciferase reporter viruses pseudotyped with baseline (black solid lines) and MVC failure Envs (black dotted lines)

More information

From Mosquitos to Humans: Genetic evolution of Zika Virus

From Mosquitos to Humans: Genetic evolution of Zika Virus Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical

More information

Metro St. Louis HIV Epidemiological Profile

Metro St. Louis HIV Epidemiological Profile Metro St. Louis HIV Epidemiological Profile Saint Louis TGA Part A Planning Council Prepared by the City of St. Louis Department of Health s Center for Health Information, Research, and Planning Table

More information

Descriptive Epidemiology of STBBIs in the Winnipeg Health Region

Descriptive Epidemiology of STBBIs in the Winnipeg Health Region Descriptive Epidemiology of STBBIs in the Winnipeg Health Region Pierre Plourde Souradet Shaw Debbie Nowicki Mandy Whitlock March 22, 211 Methods Case definitions and case reporting In Manitoba, all confirmed

More information

Original Policy Date

Original Policy Date MP 2.04.37 Laboratory Testing for HIV Tropism Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search12:2013 Return to Medical

More information

CHAPTER 1: SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS

CHAPTER 1: SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS CHAPTER : SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS Highlights In Peel, the incidence of Acquired Immunodeficiency Syndrome (AIDS) has remained low (. to. cases per,) since the introduction of the

More information